|European Case Law Identifier:||ECLI:EP:BA:2010:T050110.20100809|
|Date of decision:||09 August 2010|
|Case number:||T 0501/10|
|IPC class:||C07D 307/93|
|Language of proceedings:||EN|
|Download and more information:||
|Title of application:||Resistance-repellent retroviral protease inhibitors|
|Applicant name:||Sequoia Pharmaceuticals|
|Relevant legal provisions:||
|Keywords:||Missing Statement of Grounds|
Summary of Facts and Submissions
I. The appellant contests the decision of the examining division of the European Patent Office dated 7 September 2009 refusing European patent application No. 03723624.7.
The appellant filed a notice of appeal on 4 November 2009 and paid the appeal fee on 5 November 2009.
A written statement setting out the grounds of appeal was not filed within the four-month time limit provided for in Article 108 EPC. Nor did the notice of appeal contain anything that might be considered as such statement.
II. In a communication dated 18 March 2010, the Board informed the appellant that no statement setting out the grounds of appeal had been received and that the appeal could be expected to be rejected as inadmissible. The appellant was informed that any observations should be filed within two months.
III. The appellant filed no observations in response to said communication.
Reasons for the Decision
As no written statement setting out the grounds of appeal was filed within the time limit provided for in Article 108 EPC, the appeal is inadmissible pursuant to Rule 101(1) EPC.
For these reasons it is decided that:
The appeal is rejected as inadmissible.